Stock & Company Details
AbCellera Biologics Inc $ABCL
Price:
N/A
N/A
307M
$4.4B
52 Week High:
N/A
10 Day Average Volume:
N/A
-24.01
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ABCL technical indicators
Latest AbCellera Biologics Inc (ABCL) indicator readings as of 2026-10-29.
ABCL's 14-day RSI is 55.5, in neutral territory. At $13.08 it is trading 92.0% above its 200-day moving average of $6.81, and above its 50-day average of $12.27. Price sits in the middle of its Bollinger Bands ($11.19 to $13.90). ADX reads 16.1, indicating a range-bound market rather than a trend.
Overview
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the most effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and leading pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.
Finance Bot
Ask your questions
Start by typing a question below.
